Avatrombopag for Thrombocytopenia in People With Cancer

NCT04437953 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of accrual

Conditions

Thrombocytopenia
Cancer
Liver Diseases

Interventions

DRUG: Avatrombopag

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]